Vismodegib in advanced basal-cell carcinoma.

n engl j med 367;10 nejm.org september 6, 2012 969 tive analysis of safety and outcome of 94 pediatric patients. Crit Care 2010;14:R156. 3. Thomas GL, Wigmore T, Clark P. Activated protein C for the treatment of fulminant meningococcal septicaemia. Anaesth Intensive Care 2004;32:284-7. 4. Vincent J-L, Nadel S, Kutsogiannis DJ, et al. Drotrecogin alfa… (More)